Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.-论文-万方医学网

第一作者： Gilles,Montalescot

第一单位： ACTION Study Group, Institut de Cardiologie, UPMC Université Paris 6, INSERM UMRS-1166 Paris, Centre Hospitalier Universitaire Pitié-Salpêtriėre (AP-HP), Paris, France. Electronic address: gilles.montalescot@psl.aphp.fr.

作者： Gilles,Montalescot ^[1] ; Jean-Philippe,Collet ^[2] ; Patrick,Ecollan ^[3] ; Leonardo,Bolognese ^[4] ; Jurrien,Ten Berg ^[5] ; Dariusz,Dudek ^[6] ; Christian,Hamm ^[7] ; Petr,Widimsky ^[8] ; Jean-François,Tanguay ^[9] ; Patrick,Goldstein ^[10] ; Eileen,Brown ^[11] ; Debra L,Miller ^[11] ; LeRoy,LeNarz ^[11] ; Eric,Vicaut ^[12] ; ACCOAST Investigators

作者单位： ACTION Study Group, Institut de Cardiologie, UPMC Université Paris 6, INSERM UMRS-1166 Paris, Centre Hospitalier Universitaire Pitié-Salpêtriėre (AP-HP), Paris, France. Electronic address: gilles.montalescot@psl.aphp.fr. ^[1] ACTION Study Group, Institut de Cardiologie, UPMC Université Paris 6, INSERM UMRS-1166 Paris, Centre Hospitalier Universitaire Pitié-Salpêtriėre (AP-HP), Paris, France. ^[2] ACTION Study Group, SMUR, Centre Hospitalier Universitaire Pitié-Salpêtriėre (AP-HP), Paris, France. ^[3] Cardiovascular and Neurological Department, Azienda Ospedaliera, Arezzo, Italy. ^[4] Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands. ^[5] Institute of Cardiology, Jagiellonian University Medical College, University Hospital, Krakow, Poland. ^[6] Kerckhoff Heart and Thoraxcenter, Bad Nauheim and Medical Clinic I, University of Giessen, Giessen, Germany. ^[7] Third Medical Faculty of Charles University and University Hospital Royal Vineyards, Prague, Czech Republic. ^[8] Montreal Heart Institute, Montreal, Quebec, Canada. ^[9] SAMU and Emergency Department, Lille University Hospital, Lille, France. ^[10] Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana. ^[11] ACTION Study Group, Methodology and Statistical Unit, Centre Hospitalier Universitaire Lariboisière (AP-HP), Université Paris 7, Paris, France. ^[12]

医学主题词老年人(Aged);血管造影术(Angiography);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);心电描记术(Electrocardiography);终点测定(Endpoint Determination);女(雌)性(Female);出血(Hemorrhage);人类(Humans);手术中并发症(Intraoperative Complications);男(雄)性(Male);中年人(Middle Aged);心肌梗死(Myocardial Infarction);哌嗪类(Piperazines);血小板聚集抑制剂(Platelet Aggregation Inhibitors);血小板糖蛋白GPⅡb-Ⅲa复合物(Platelet Glycoprotein GPIIb-IIIa Complex);手术前护理(Preoperative Care);危险性评估(Risk Assessment);噻吩类(Thiophenes);治疗结果(Treatment Outcome)

DOI 10.1016/j.jacc.2014.08.053

PMID 25524333

发布时间 2017-10-28

检索历史清除

Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.

Journal of the American College of Cardiology

相似文献

同项目论文

Journal of the American College of Cardiology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.

Journal of the American College of Cardiology

相似文献

同项目论文

Journal of the American College of Cardiology

相关期刊

检索历史清除